In this guide, learn the eligibility criteria for brand-name semaglutide, cost and insurance coverage, safety risks of compounded semaglutide and how to find a reputable telehealth provider online.

The Food and Drug Administration (FDA) on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply. The FDA's move is bad news for ...

This article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.